Shana Veale - PharmChem VP CFO

PCHM Stock  USD 3.16  0.02  0.63%   

Insider

Shana Veale is VP CFO of PharmChem
Phone855-458-4100
Webhttps://www.pharmchek.com

PharmChem Management Efficiency

The company has return on total asset (ROA) of (0.0537) % which means that it has lost $0.0537 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.2367) %, meaning that it created substantial loss on money invested by shareholders. PharmChem's management efficiency ratios could be used to measure how well PharmChem manages its routine affairs as well as how well it operates its assets and liabilities.

Similar Executives

Showing other executives

INSIDER Age

Arpa GarayMerck Company
42
Michelle WeeseBristol Myers Squibb
50
Paul HudsonSanofi ADR
58
Cari GallmanBristol Myers Squibb
N/A
MBA DVMAstraZeneca PLC ADR
66
Diana ConradGlaxoSmithKline PLC ADR
N/A
Robert PharmDNovartis AG ADR
57
Michael QuigleyGilead Sciences
N/A
Sarah EltonFarrGlaxoSmithKline PLC ADR
N/A
Timothy PowerBristol Myers Squibb
N/A
Stephen MayoMerck Company
59
Gonzalo VinaAstraZeneca PLC ADR
N/A
Deborah EldracherAstraZeneca PLC ADR
59
BCH BMBristol Myers Squibb
57
Patrice BulaNovartis AG ADR
65
Tim PowerBristol Myers Squibb
N/A
Dean LiMerck Company
58
Julie BrownGlaxoSmithKline PLC ADR
62
Sally JacksonGlaxoSmithKline PLC ADR
52
Jennifer MauerMerck Company
N/A
Victor BultoNovartis AG ADR
47
PharmChem, Inc. provides PharmChek Sweat Patch that is used to detect drugs of abuse. Its PharmChek Sweat Patch uses sweat as the source and offers alternative to urine testing for cocaine, opiates, amphetamines, PCP, and marijuana. Pharmchem is traded on OTC Exchange in the United States. PharmChem [PCHM] is a Pink Sheet which is traded between brokers as part of OTC trading.

Management Performance

PharmChem Management Team

Elected by the shareholders, the PharmChem's board of directors comprises two types of representatives: PharmChem inside directors who are chosen from within the company, and outside directors, selected externally and held independent of PharmChem. The board's role is to monitor PharmChem's management team and ensure that shareholders' interests are well served. PharmChem's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, PharmChem's outside directors are responsible for providing unbiased perspectives on the board's policies.
Shana Veale, VP CFO
Matt Katz, Chief Officer
Kerri Wagner, Chief Officer

PharmChem Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is PharmChem a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

Other Information on Investing in PharmChem Pink Sheet

PharmChem financial ratios help investors to determine whether PharmChem Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in PharmChem with respect to the benefits of owning PharmChem security.